Concepedia
Statistics
Publications
38
Citations
1.2K
H-Index
23
Active since
1995
Affiliations
AstraZeneca (United Kingdom)(Current)
AstraZeneca (Brazil)
University of Cambridge
Cancer Research UK
AstraZeneca (Sweden)
Jeremy S. Parker is an author at AstraZeneca (United Kingdom) specializing in chemistry, engineering, and organic chemistry.
Top concepts
EngineeringChemistryOrganic ChemistryPharmacologyMedicineCatalysisNatural SciencesDrug DiscoveryMedicinal ChemistryBiochemistry
Publications per year
1995–2022
A general approach for the site-selective modification of native proteins, enabling the generation of stable and functional antibody–drug conjugates
Stephen J. Walsh, Soleilmane Omarjee, Warren R. J. D. Galloway et al. · Chemical Science · 2018 · 120 citations · Full text
Design and optimisation of dendrimer-conjugated Bcl-2/xL inhibitor, AZD0466, with improved therapeutic index for cancer therapy
Claire Patterson, Srividya B. Balachander, Iain Grant et al. · Communications Biology · 2021 · 89 citations · Full text
Manganese(III) Acetate Mediated Oxidative Radical Cyclizations. Toward Vicinal All-Carbon Quaternary Stereocenters
Angus W. J. Logan, Jeremy S. Parker, Michal S. Hallside et al. · Organic Letters · 2012 · 56 citations
Inorganic Chemistry, Chemical Engineering, Novel Organocatalysts +13
Studies towards a postulated biomimetic Diels-Alder reaction for the synthesis of himgravine
Jack E. Baldwin, Richard Chesworth, Jeremy S. Parker et al. · Tetrahedron Letters · 1995 · 49 citations
Bioorganic Chemistry, Biochemistry, Natural Sciences +2
A Robust First-Pass Protocol for the Heck–Mizoroki Reaction
Paul M. Murray, John F. Bower, David K. Cox et al. · Organic Process Research & Development · 2013 · 48 citations
Hm Reactions, Cross-coupling Reaction, Engineering +12
1–5 of 38